CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer. Patel UA, Shi MY, Kazan JM, Nixon KCJ, et al. Mol Cancer Ther 2025 Sep 3. doi: 10.1158/1535-7163.MCT-24-0861.

Read + Share

Amedeo Smart

Independent Medical Education

Patel UA, Shi MY, Kazan JM, Nixon KCJ, et al. CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer. Mol Cancer Ther 2025 Sep 3. doi: 10.1158/1535-7163.MCT-24-0861.
PMID: 40899441